The following was sent to The Oncologist is response to a series of articles (11/02) in their CME (continuing medical education) series on Capcetabine. The articles discussed its use alone and with other chemotherapies. Comments sent via THE ONCOLOGIST Feedback Page NAME: Ann Fonfa The Annie Appleseed Project EMAIL: annfonfa@aol.com COMMENTS: I was very pleased to see reports of studies using lower doses (than FDA-approved label) of capecitabine. As a patient and advocate, I am convinced that the FDA- approved dose is too high. In the clinic, I have been told that "doctors in the know" are reducing the dose to help limit toxicity. Of course the very concept of "doctors in the know" implies that others are NOT in the know. Thus the presentation in your journal of studies with other, lower doses than the FDA-approved one is encouraging. Ann Fonfa, Founder The Annie Appleseed Project www.annieappleseedproject.org 11/02 Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.